Atazanavir sulfate

Détails pour le produit réf. ABIN3220131
Application
Inhibition Assay (InhA), Functional Studies (Func)
Options
Fonction Atazanavir (formerly known as BMS-232632) is an antiretroviral drug of the protease inhibitor (PI) class. Like other antiretrovirals, it is used to treat infection of human immunodeficiency virus (HIV). Atazanavir is distinguished from other PIs in that it can be given once-daily (rather than requiring multiple doses per day) and has lesser effects on the patient's lipid profile (the amounts of cholesterol and other fatty substances in the blood). Like other protease inhibitors, it is used only in combination with other HIV medications. The U.S. Food and Drug Administration (FDA) approved atazanavir on June 20, 2003.
Attributs du produit Tradename: BMS-232632-05, Reyataz
Source of Compound: synthetic
Target: HIV Protease inhibitor
Receptor: HIV Protease
Purification All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
Pureté 99 %
Formula C38H52N6O7.H2SO4
Solubility Soluble in DMSO
Sujet Microbiology & Virology,Proteases/Proteasome
Poids moléculaire 802.93 g/mol
Numéro CAS 229975-97-7
Indications d'application Optimal working dilution should be determined by the investigator.
Restrictions For Research Use only
Format Solid
Stock -20 °C
Stockage commentaire For the majority of compounds, they could be dissolved in DMSO or other organic solvent.
Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience.
Several freeze/thaw cycles should not damage the activity of our small molecule products.
However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours.
Date de péremption 24 months